BR0212295A - Test - Google Patents
TestInfo
- Publication number
- BR0212295A BR0212295A BR0212295-2A BR0212295A BR0212295A BR 0212295 A BR0212295 A BR 0212295A BR 0212295 A BR0212295 A BR 0212295A BR 0212295 A BR0212295 A BR 0212295A
- Authority
- BR
- Brazil
- Prior art keywords
- potassium channel
- assay
- test
- eag
- compounds
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
"ENSAIO". A invenção refere-se a um ensaio para estabelecer a afinidade de compostos no canal (K+) de potássio "ether-a-go-go" (EAG), em particular o canal de potássio EAG humano (hERG),utilizando um bloqueador de canal de potássio de retificação para o interior rotulado (IKR). Esse ensaio é útil para identificar compostos com efeitos indesejáveis em repolarização cardíaca no homem, em particular a propensão de prolongar o intervalo QT no eletrocardiograma."TEST". The invention relates to an assay for establishing the affinity of compounds in the ether-a-go-go (EAG) potassium channel (K +), in particular the human EAG potassium channel (hERG) using a labeled rectifying potassium channel (IKR). This assay is useful for identifying compounds with undesirable effects on cardiac repolarization in humans, in particular the propensity to prolong the QT interval on the electrocardiogram.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0121440.2A GB0121440D0 (en) | 2001-09-04 | 2001-09-04 | Assay |
US32397301P | 2001-09-20 | 2001-09-20 | |
PCT/IB2002/003618 WO2003021271A2 (en) | 2001-09-04 | 2002-09-04 | Affinity-assay for the human erg potassium channel |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0212295A true BR0212295A (en) | 2004-10-13 |
Family
ID=26246508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0212295-2A BR0212295A (en) | 2001-09-04 | 2002-09-04 | Test |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1423700A2 (en) |
JP (1) | JP2005510691A (en) |
BR (1) | BR0212295A (en) |
CA (1) | CA2459265A1 (en) |
IL (1) | IL160674A0 (en) |
MX (1) | MXPA04002058A (en) |
PL (1) | PL370539A1 (en) |
WO (1) | WO2003021271A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9701144D0 (en) † | 1997-03-27 | 1997-03-27 | Pharmacia & Upjohn Ab | Novel compounds, their use and preparation |
EP0957073A1 (en) | 1998-05-12 | 1999-11-17 | Schwarz Pharma Ag | Novel derivatives of 3,3-diphenylpropylamines |
DE10315917A1 (en) * | 2003-04-08 | 2004-11-18 | Schwarz Pharma Ag | Highly pure bases of 3,3-diphenylpropylamine monoesters |
SE0302775D0 (en) * | 2003-10-20 | 2003-10-20 | Astrazeneca Ab | Chemical compound and assay |
US7927820B2 (en) | 2004-07-20 | 2011-04-19 | Janssen Pharmaceutica Nv | Assay systems and methods for detecting molecules that interact with membrane channels |
US7326772B2 (en) * | 2005-05-12 | 2008-02-05 | Penta Biotech, Inc. | Peptide for assaying hERG channel binding |
EP1801200B1 (en) | 2005-12-21 | 2010-03-31 | F. Hoffmann-La Roche Ag | Stable cell lines expressing hERG |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2415295C (en) * | 2000-07-14 | 2010-02-16 | Merck & Co., Inc. | Radioligand and binding assay |
-
2002
- 2002-09-04 IL IL16067402A patent/IL160674A0/en unknown
- 2002-09-04 JP JP2003525303A patent/JP2005510691A/en not_active Withdrawn
- 2002-09-04 CA CA002459265A patent/CA2459265A1/en not_active Abandoned
- 2002-09-04 MX MXPA04002058A patent/MXPA04002058A/en not_active Application Discontinuation
- 2002-09-04 BR BR0212295-2A patent/BR0212295A/en not_active IP Right Cessation
- 2002-09-04 PL PL02370539A patent/PL370539A1/en not_active Application Discontinuation
- 2002-09-04 EP EP02762684A patent/EP1423700A2/en not_active Withdrawn
- 2002-09-04 WO PCT/IB2002/003618 patent/WO2003021271A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2459265A1 (en) | 2003-03-13 |
MXPA04002058A (en) | 2004-06-07 |
WO2003021271A3 (en) | 2003-12-18 |
JP2005510691A (en) | 2005-04-21 |
WO2003021271A2 (en) | 2003-03-13 |
PL370539A1 (en) | 2005-05-30 |
IL160674A0 (en) | 2004-08-31 |
EP1423700A2 (en) | 2004-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60218721D1 (en) | Pyrimidinone als melanin concentrating hormone receptor 1 | |
PT1135391E (en) | NEW COMPOUNDS OF TIAZOLO (4,5-D) PYRIMIDINE | |
ECSP034503A (en) | CYCLE SELECTIVE PEPTIDES | |
UY27079A1 (en) | PROCEDURE FOR THE PREPARATION OF AN ANTICHOLINERGIC | |
TWI319011B (en) | Diagnosis and treatment of cancers and other conditions | |
TR200100410T2 (en) | 2- (purin-9-yl) -tetrahydrofuran-3,4-diol derivatives. | |
BR0210253A (en) | Process for telomerization of non-cyclic olefins | |
ID23971A (en) | PROSTAGLANDIN TETRAHIDRO SUBSTITUTEDIC C <16> -C <20> AROMATICS USING AS FP AGONISTS | |
EA200300716A1 (en) | HETEROCYCLILALKILINDOL OR-ASAINDOL COMPOUNDS AS LIGAND 5-HYDROXYTRIPTAMINE-6 | |
IL160045A0 (en) | Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues | |
MX9804588A (en) | Use of halogen bleach-comprising compositions for improved mildness to the skin. | |
TR200002380T2 (en) | New triazolo (4,5-d) pyrimidine compounds | |
IT1293778B1 (en) | 1,4,7,10-TETRAAZABICICLO (8.2.2.)TETRADECAN-2 ONE, ITS PREPARATION AND USE FOR THE PREPARATION OF TETRAAZAMACROCYCLES | |
BR0212295A (en) | Test | |
SV1999000060A (en) | PROCEDURE FOR THE PREPARATION OF (S, S) -BENCIL-2,8-DIAZABICICLO 4.3.0 NONANO REF. 32965-SV | |
BR9713176A (en) | Amorphous benzothiophenes, methods of preparation and methods of use | |
ATE416174T1 (en) | SUBSTITUTED HOMOPIPERIDYLBENZIMIDAZOLE ANALOGS AS FUNDUS RELAXANTS | |
NO20011664L (en) | High purity composition comprising (7 <alpha>, 17 <alpha>) - 17-hydroxy-7-methyl-19-nor-17-pregn-5 (10) -en-20-yn-3-one | |
DE69805002D1 (en) | KV2.1 ANTAGONISTS | |
PT878195E (en) | USE OF A 2-AROYL-3-ARYBENZO COMPOUND (B) THYROFEN FOR REDUCING FIBRINOGEN | |
CA2345724A1 (en) | Use of acylcarnitines as antitumour agents | |
BR9917088A (en) | Process for the preparation of unsubstituted deaza adenosine derivatives | |
BR0214244A (en) | Use of an ascomycin | |
AR020785A1 (en) | NEW CHEMICAL PROCEDURES | |
NO960849L (en) | Difluorostatone antiviral analogs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A,6A E 7A ANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2029 DE 24/11/2009. |